1. PROTAC Protein Tyrosine Kinase/RTK Apoptosis
  2. PROTACs FGFR Apoptosis
  3. PROTAC FGFR2 degrader 1

PROTAC FGFR2 degrader 1 (compound N5) 是一种有效靶向 FGFR2PROTACDC50 为 6.46 nM,IC50 为 0.08 nM。 PROTAC FGFR2 degrader 1 具有抗增殖活性和高度选择性,通过降低 FGFR2 下游蛋白 p-ERK 和 p-PLCγ 的激活,诱导 KATOIII 和 SNU16 周期阻滞于 G0/G1 期,抑制细胞凋亡 (Apoptosis)。 PROTAC FGFR2 degrader 1 在 0.17 nM 浓度下对胃癌细胞的抑制率保持在50%以上。 PROTAC FGFR2 degrader 1 有效抑制了小鼠模型中 SNU16 异种移植肿瘤的生长 (Srtucture Note: Pink,FGFR2 激活剂:HY-18708; Blue,E3 连接酶配体:HY-10984; Black,linker:HY-163989; E3连接酶配体 + linker:HY-163986)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

PROTAC FGFR2 degrader 1 Chemical Structure

PROTAC FGFR2 degrader 1 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PROTAC FGFR2 degrader 1 (compound N5) is a PROTAC that effectively targets FGFR2 with DC50 of 6.46 nM, the FGFR2 IC50 is 0.08 nM. PROTAC FGFR2 degrader 1 has anti-proliferative activity and highly selective, induces G0/G1 arrest of KATOIII and SNU16 cell cycle and inhibits apoptosis by reducing the activation of p-ERK and p-PLCγ, the downstream proteins of FGFR2. PROTAC FGFR2 degrader 1 inhibits gastric cancer cells remained above 50% at a concentration of 0.17 nM. PROTAC FGFR2 degrader 1 potently inhibits the growth of SNU16 xenograft tumors in mouse model (Srtucture Note: Pink, FGFR2 activator: HY-18708; Blue, E3 ligase ligand: HY--10984; Black, linker: HY-163989; E3 ligase ligand + linker:HY-163986) [1].

IC50 & Target

FGFR2

 

体外研究
(In Vitro)

PROTAC FGFR2 degrader 1 (0-1000 nM; 72 h) 对 KATO III 和 SNU16 的 IC50 均小于 0.17 nM[1]
PROTAC FGFR2 degrader 1 (500 nM; 12 h; WB) 诱导 KATO III 中 FGFR2 降解,对 FGFR2 具有高度选择性,且是 UPS 依赖性的[1]
PROTAC FGFR2 degrader 1 (500,1000 nM; 24 h) 诱导 KATO III 和 SNU16 细胞在 G0/G1 期的细胞周期阻滞。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: KATO III, SNU16
Concentration: 0, 0.1, 1, 10, 100, 500, 1000 nM
Incubation Time: 0, 1, 6, 12, 24, 36 h
Result: Degraded FGFR2 in Kato III cells with timedependent. Induced FGFR2 degradation in SNU16 cells in vivo in a mouse model. Decreased CDK2, CDK 4, Cyclin D1 and Cyclin E.

Western Blot Analysis[1]

Cell Line: KATO III, SNU16
Concentration: 500 nM, 12 h; Pomalidomide (10 μM), Erdafitinib (10 μM), MG132 (5 μM) for 6 h; 50, 100, 500 nM for 24 h
Incubation Time: 12 h; 24 h
Result: Degraded FGFR2 via the UPS pathway, and degradation of FGFR2 was dependent on the formation of the FGFR2-N5-E3 ligase complex and subsequent proteasomal degradation. Showed that phosphorylation of p-AKT was decreased in both SNU16 and Kato III cells, inhibited the activation of p-ERK and p-PLC γ effectively.

Real Time qPCR[1]

Cell Line: KATO III
Concentration: 500 nM
Incubation Time: 12 h
Result: Degraded FGFR2 in KATOIII with high selectivity.

Cell Cycle Analysis[1]

Cell Line: KATO III, SNU16
Concentration: 500, 1000 nM
Incubation Time: 24 h
Result: Showed that the percentage of KATO III cells in the G0/G1 phase increased from 47.7% to 67.1% in the 1000 nM of PROTAC FGFR2 degrader 1, the number of SNU16 cells increased from 45.9% to 67.5%.

Apoptosis Analysis[1]

Cell Line: KATO III, SNU16
Concentration: 1000 nM
Incubation Time: 24 h
Result: Showed that the apoptosis rate of KATO III cells increased from 10.9% in the DMSO group to 30.5%, upregulation of cleaved caspase 3 was observed.
体内研究
(In Vivo)

PROTAC FGFR2 degrader 1 (10 mg/kg, 20 mg/kg; Intraperitoneal injection) 在皮下异种移植 SNU16 小鼠模型中抑制胃癌细胞生长,降低肿瘤重量[1]
PROTAC FGFR2 degrader 1在SD大鼠体内的药动学特征[1]

Parameters PROTAC FGFR2 degrader 1 2mg/kg(i.v.) Parameters PROTAC FGFR2 degrader 1 2mg/kg(i.p.)
t1/2 (h) 4.65±4.14 t1/2 (h) 7.59±0.365
Tmax (h) / Tmax (h) 0.25±0.177
Cmax (ng/mL) / Cmax (ng/mL) 302±33.7
MRTinf (h) 2.27±1.44 MRTinf (h) 6.53±0.0721
CL (mL/min/kg) 59.3±8.35 CL/F (mL/min/kg) 78.2±1.62
Vss (L/kg) 7.58±3.80 VZ/F (L/kg) 51.4±2.40
AUC0-t (h*ng/mL) 544±74.2 AUC0-t (h*ng/mL) 991±20.7
AUC0-inf (h*ng/mL) 570±83.3 AUC0-inf (h*ng/mL) 1066±21.9
AUC0-t/ AUC0-inf 0.956±0.0232 AUC0-t/ AUC0-inf 0.930±0.00429
F / F (%) 74.8±1.53

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SD rats[1]
Dosage: 2, 5 mg/kg
Administration: Intravenous injection (i.v.); Intraperitoneal injection (i.p.)
Result: Absorbed rapidly in vivo, reached its maximum concentration at 0.25 h by 5 mg/kg, and then slowly cleared from the body, with a half-life of 7.59 h.
Animal Model: A mouse model of subcutaneous xenograft of SNU16 tumor[1]
Dosage: 10, 20 mg/kg
Administration: Intraperitoneal injection(i.p.); once daily; 25 days
Result: Showed the stronger anti-tumor effect, greater tumor growth inhibition and a significant reduction in tumor weight.
分子量

858.98

Formula

C46H54N10O7

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
PROTAC FGFR2 degrader 1
目录号:
HY-163985
需求量: